Loading...

Posidedn (Еtoposide) Vial 100 mg/5 ml

22

Posidedn™ 100 is a prescription antineoplastic medicinal product based on etoposide. It is used as part of combined chemotherapy in the treatment of various malignant neoplasms. Intended for intravenous administration after dilution. Used exclusively as prescribed by an oncologist.

Description

Posidedn™ 100 is a cytotoxic antitumor medicinal product from the group of agents used in chemotherapy, containing etoposide in the form of an injectable solution. The medicine is used in oncological practice only under medical supervision.

🔹 General Characteristics

Etoposide is an antineoplastic agent of plant origin and is widely used in combined chemotherapy regimens. The medicine acts predominantly on rapidly dividing tumor cells.

🔹 Mechanism of Action

Etoposide inhibits the enzyme topoisomerase II, which is essential for DNA replication. As a result:

  • the cell cycle is arrested;

  • DNA structure is damaged;

  • malignant cells undergo destruction.

🔹 Indications for Use

The medicine is used in the treatment of various oncological diseases, including:

  • lung cancer (especially small cell lung cancer);

  • Hodgkin lymphoma and non-Hodgkin lymphomas;

  • leukemias;

  • ovarian cancer;

  • other malignant tumors — as part of combined chemotherapy.

The treatment regimen and dosage are determined individually by an oncologist.

🔹 Method of Administration

  • administered intravenously after prior dilution;

  • infusion is performed by qualified medical personnel;

  • dosage, duration, and frequency depend on the treatment protocol;

  • often used in combination with other cytostatic agents.

🔹 Contraindications

  • hypersensitivity to etoposide or any component of the product;

  • severe myelosuppression;

  • acute infections;

  • pregnancy and breastfeeding (unless the benefit outweighs the risk);

  • severe hepatic or renal impairment — with caution.

🔹 Special Warnings

  • treatment must be carried out under strict medical supervision;

  • regular monitoring of hematological parameters is required;

  • increased risk of infections may occur;

  • the medicine is cytotoxic and requires adherence to safety precautions during handling.

🔹 Adverse Reactions

Possible adverse effects include:

  • leukopenia, neutropenia, thrombocytopenia;

  • nausea, vomiting, diarrhea;

  • alopecia;

  • stomatitis;

  • general weakness, fatigue;

  • changes in liver function parameters.

🔹 Storage Conditions

  • store at temperatures between +2°C and +8°C;

  • store in the original packaging;

  • protect from light and moisture;

  • do not freeze;

  • keep out of reach of children.

🔹 Important

The medicine is intended exclusively for professional medical use, in hospital settings or specialized oncology centers.

Additional information

Active ingredient

Etoposide

Strength

100 mg / 5 ml

Dosage form

Injectable solution

Package:

1 vial

Country of manufacture

India

Reviews

There are no reviews yet.

Be the first to review “Posidedn (Еtoposide) Vial 100 mg/5 ml”

Your email address will not be published. Required fields are marked *

×
×

Cart